CLINICAL_TRIALS
trial_result
· 2017-03-31
Clinical Trial Update: Study of the Durability of Glycemic Control With Nateglinide [Phase 4]
Summary
Phase 4 study evaluating the durability of glycemic control with nateglinide in type 2 diabetes has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ajou University School of Medicine | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2017-03-31